发明名称 |
FORMULATIONS OF LYCOPENE IN COMBINATION WITH BISPHOSPHONATES BONE RESORPTION INHIBITORS |
摘要 |
The present invention provides a pharmaceutical formulation suitable for filling softgel capsules comprising: (a) from about 1% to about 90% by weight of a bisphosphonic acid or a pharmaceutically acceptable salt; (b) from 1% to about 99% by weight of lycopene and (c) from about 40% to about 80% by weight of a liquid carrier comprising 50% to 80% by weight polyethylene glycol; 5% to 15% by weight of glycerin; and 5% to 20% by weight water. The invention also describes a method for preparing alendronate or its pharmaceutical acceptable salts in encapsulated therapeutic dosage form in combination with lycopene. |
申请公布号 |
US2014356423(A1) |
申请公布日期 |
2014.12.04 |
申请号 |
US201313903999 |
申请日期 |
2013.05.28 |
申请人 |
Angres Isaac A. |
发明人 |
Angres Isaac A. |
分类号 |
A61K31/66;A61K31/01;A61K9/48 |
主分类号 |
A61K31/66 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutical composition comprising:
(a) effective amounts of a bone resorption inhibitor; and (b) effective amounts of lycopene. |
地址 |
North Potomac MD US |